Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALDAY: Mirogabalin for Fibromyalgia Pain
NCT02146430Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Oct 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of mirogabalin in fibromyalgia (FM), sponsored by Daiichi Sankyo Co., Ltd.. Started Oct 2014; status: completed.
02
Drugs
mirogabalin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT02146430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02146430.